Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhGM-CSF as Adjuvant Immunotherapy in Colon Cancer
NCT02466906Phase 2Unknown
- Sponsor
- 307 Hospital of the People's Liberation Army
- Start
- Jun 2015
- Primary completion
- Jun 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in colon cancer, sponsored by 307 Hospital of the People's Liberation Army. Status: unknown.
02
Drugs
sargramostim
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT02466906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02466906.